Xtl Biopharmaceuticals XTLB Cash Flow Statement (2009-2025)

NASDAQ XTLB
$1.96 0.00 (-0.01%)
As of: Oct 19, 2026 · 12:25 PM EDT
Reported Financials

Xtl Biopharmaceuticals Quarterly Cash Flow Statement

Periods 65 quarters
Latest Dec 2025

Xtl Biopharmaceuticals cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 65 quarters of results from Mar 2009 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Dec2025
Operating Activities
Net Income
-1.11M-3.00-2.001.00-1.15M-0.80M2.10M-0.25M-0.29M-0.82M-0.75M-0.25M-0.16M-0.22M-0.28M-0.18M-0.42M-0.55M-0.26M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
Share-based CompensationStock Comp.
Gains from Investment SecuritiesGains Investment
-0.22M-0.37M0.45M1.04M-0.07M-0.13M-0.09M0.22M-0.57M-0.65M-0.53M-0.66M-0.18M-0.05M-0.14M0.67M-0.28M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
0.78M-0.50M
Non-cash ItemsNon-Cash Items
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
Change in TaxesChange Taxes
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
Other Operating ActivitiesOther Ops.
Cash from OperationsCash from Ops.
Investing Activities
Capital ExpendituresCapex
Change in Property, Plant and EquipmentChange in PP&E
Change in IntangiblesChange Intangibless
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Sale and Maturity of InvestmentsInvestments Sold
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
Cash from Financing ActivitiesCash from Financing
Additional items
Exchange Rate EffectFX Effect
Change in Cash
Ending Cash Balance
4.03M3.63M2.92M2.97M2.35M2.09M1.40M0.37M0.08M
Free Cash FlowFCF
Net Cash FlowNCF
Income Taxes PaidTaxes Paid

Xtl Biopharmaceuticals Cash Flow Statement API

Pull Xtl Biopharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XTLB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY